Mark H Skolnick - Chief Scientific Officer, Myriad Genetics Inc

As of November 6, 2009


Mark H Skolnick Net Worth

  • Net worth is estimated to be at least $26.58M
  • Owns at least 34,000 units of Myriad Genetics Inc stock
  • Sold an estimated value of $15.28M in the last 6 years at Myriad Genetics Inc

Mark H Skolnick Compensation at Myriad Genetics Inc in 2020 Transition Period

  • Earned a $204,651 salary
  • Rewarded $879,288 in stock value and options
  • Received a total compensation of $1,235,335

Mark H Skolnick Trading

  • Largest purchase of shares was 80,028 units , worth over $1.06M on November 6, 2009
  • Largest sale of shares was 315,246 units , worth over $4.88M on November 6, 2009
  • In total has made about 41 transactions over 6 years
  • Usually trades in February, with the busiest year in 2008
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark H Skolnick Mailing Address

  • Mailing address is Myriad Genetics Inc 320 Wakara Way Salt Lake City UT 84108 UT

Myriad Genetics Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Paul J. Diaz 2020 Transition Period $382,663 $8,394,628 $5,500,006 $682,000 $541,524 $15,500,821
R. Bryan Riggsbee 2020 Transition Period $265,454 $1,264,541 - $281,174 $5,237 $1,816,406
R. Bryan Riggsbee 2020 $552,796 $3,461,500 - $180,209 $8,836 $4,203,341
R. Bryan Riggsbee 2019 $466,650 $2,392,500 - $260,671 $19,162 $3,138,983
R. Bryan Riggsbee 2018 $432,000 $1,954,200 - $254,016 $5,366 $2,645,582
Jerry S. Lanchbury, Ph.D. 2020 Transition Period $256,618 $1,102,569 - $176,253 $5,827 $1,541,267
Jerry S. Lanchbury, Ph.D. 2020 $493,496 $1,197,200 - $131,599 $6,943 $1,829,238
Jerry S. Lanchbury, Ph.D. 2019 $508,595 $1,914,000 - $250,228 $12,927 $2,685,750
Jerry S. Lanchbury, Ph.D. 2018 $493,782 $1,628,500 - $244,422 $10,972 $2,377,676
Nicole Lambert 2020 Transition Period $217,726 $1,243,641 - $194,472 $5,542 $1,661,381
Nicole Lambert 2020 $386,859 $1,197,200 - $99,934 $20,713 $1,704,706
Mark Verratti 2020 Transition Period $204,651 $879,288 - $143,273 $8,123 $1,235,335
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899923/000089992321000031/a2021proxystatement.htm

Myriad Genetics Inc Insider Trading

  • The most recent transaction was 945 units sold on August 30, 2021 by Nicole Lambert worth over $32.6K
  • In the last 17 years, insiders at Myriad Genetics Inc sold an estimated value of $314.86M and bought an estimated value of $123.88M
  • The most active traders are Jerry S Lanchbury, Chief Scientific Officer,  Richard Marsh, E.V.P.,  and Peter D Meldrum, President & C.E.O.
  • Insider trading is most common in September, with the busiest year in 2007

MYRIAD GENETICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1